Stocks/JCI

JCI three-lens brief

Evidence-based stock research on JCI. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of Jul 10
$102.09$141.68$151.18

Performance

1W
+0.7%
1M
-3.7%
3M
-0.6%
6M
+27.8%
YTD
+18.3%
1Y
+33.2%
3Y
5Y
JCI · Nightly brief
Watch

JCI moved +0.82% overnight.

  • Earnings scheduled 2026-07-28.

JCI closed at $141.68 (+0.82%) as of 2026-07-10. Market cap: $86.44B. P/E (trailing) 43.3. Price is below the 50-day MA and above the 200-day MA. Last quarter: Revenue $6.14B, net income $613.00M, free cash flow $2.87B. Watching for: 2026-07-28 earnings release (17 days out).

Market ✓· Fundamentals ✓· 1 events
Informational only · Not investment advice
Three-lens method

Why three lenses on JCI, not one.

A single reasoning model has blind spots it doesn’t know about. We examine JCIacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/JCI"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath JCI brief"></iframe>